Lactobacillus acidophilus ATCC 4356 attenuates the atherosclerotic progression through modulation of oxidative stress and inflammatory process.
- 2013-09
- International Immunopharmacology 17(1)
- Lihua Chen
- Wenen Liu
- Yan-Ming Li
- San Luo
- Qingxia Liu
- Yi-ming Zhong
- Zi-juan Jian
- Meihua Bao
- PubMed: 23747589
- DOI: 10.1016/j.intimp.2013.05.018
- Low evidence
ApoE(-/-) mice in the vehicle group showed higher levels of ... tumor necrosis factor-alpha (TNF-α), but lower levels of interleukin-10 (IL-10) ... Administration of L. acidophilus ATCC 4356 could reverse these trends in a dose-dependent manner in ApoE(-/-) mice.
- Effect
- Beneficial
- Effect size
- Moderate